- Home
- ONCY vs DTF Comparison
ONCY vs DTF Comparison
Compare ONCY & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- DTF
- Stock Information
- Founded
- ONCY 1998
- DTF 1991
- Country
- ONCY Canada
- DTF United States
- Employees
- ONCY N/A
- DTF N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- DTF Investment Managers
- Sector
- ONCY Health Care
- DTF Finance
- Exchange
- ONCY Nasdaq
- DTF Nasdaq
- Market Cap
- ONCY 89.7M
- DTF 79.8M
- IPO Year
- ONCY 1999
- DTF N/A
- Fundamental
- Price
- ONCY $1.35
- DTF $11.33
- Analyst Decision
- ONCY Strong Buy
- DTF
- Analyst Count
- ONCY 5
- DTF 0
- Target Price
- ONCY $5.00
- DTF N/A
- AVG Volume (30 Days)
- ONCY 1.2M
- DTF 21.1K
- Earning Date
- ONCY 11-11-2025
- DTF 01-01-0001
- Dividend Yield
- ONCY N/A
- DTF 3.64%
- EPS Growth
- ONCY N/A
- DTF N/A
- EPS
- ONCY N/A
- DTF 0.44
- Revenue
- ONCY N/A
- DTF N/A
- Revenue This Year
- ONCY N/A
- DTF N/A
- Revenue Next Year
- ONCY N/A
- DTF N/A
- P/E Ratio
- ONCY N/A
- DTF $24.34
- Revenue Growth
- ONCY N/A
- DTF N/A
- 52 Week Low
- ONCY $0.33
- DTF $10.29
- 52 Week High
- ONCY $1.53
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- ONCY 64.00
- DTF 52.18
- Support Level
- ONCY $1.20
- DTF $11.32
- Resistance Level
- ONCY $1.44
- DTF $11.42
- Average True Range (ATR)
- ONCY 0.11
- DTF 0.06
- MACD
- ONCY 0.01
- DTF 0.00
- Stochastic Oscillator
- ONCY 79.07
- DTF 57.14
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.